Sign up to save your podcasts
Or
Share #19. IDO predicts death in NEN
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#19. IDO predicts death in NEN
Prof. Joerg Schefold of the Bern University Hospital, Switzerland talks about his latest publication in Neuroendocrinology - 'Increased activity of the immunoregulatory enzyme Indoleamine-2,3-dioxygenase (IDO) with consecutive tryptophan depletion predicts death in patients with neuroendocrine neoplasia"
View all episodes
By NeuroEndoNow.orgProf. Joerg Schefold of the Bern University Hospital, Switzerland talks about his latest publication in Neuroendocrinology - 'Increased activity of the immunoregulatory enzyme Indoleamine-2,3-dioxygenase (IDO) with consecutive tryptophan depletion predicts death in patients with neuroendocrine neoplasia"